Glioblastoma multiforme remains the most common and highly lethal brain cancer and is known for its ability to relapse. Researchers at The University of Texas MD Anderson Cancer Center have identified a pathway by which cancer cells aggressively spread and grow in the brain, opening up new possibil...
A data mining system for providing analytical information on brain tumors to public health decision makerdoi:10.1016/j.cmpb.2012.10.010Data analysisOntologyDecision support systemInformation systemBrain neoplasmsHealth services administrationCancer is the leading cause of death in economically developed ...
Accurate, up-to-date, comprehensive cancer information from the U.S. government's principal agency for cancer research.
patient-oriented cancer web site. There is one caveat, however: they found that the information on the peer-reviewed site was written in plainer English.
For example, a recent study1 found that approximately half of individuals surveyed wanted to know if they had a genetic predisposition to cancer, while the other half did not; half wanted to know the estimated global temperature in 2100, half did not; half wanted to know the amount of ...
On November 15, 2024, FDA approves Revumenib for relapsed or refractory acute leukemia with a KMT2A translocation.Cancer Non-Small Cell Lung Cancer Lazertinib is a Brain-penetrant and Irreversible EGFR-TKI for NSCLC researchLouis Gilman November 12, 2024 On 19 August 2024, FDA approves Lazer...
Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer. Development of high-throughput monitoring technologies enables interrogation of cancer samples at various levels of cellular activity. Capitalizing on thes... R Matthew,K Mehmet,S Roded,... - 《Plos Computation...
Brain Tumors(1) Breast Cancer(7) What's New(0) Chemotherapy(1) What's New(0) Colon Cancer(7) What's New(3) Lung Cancer(20) What's New(4) Prostate Cancer(8) What's New(2) Read information on: Recent Articles: Brain Tumors – new exciting developments ...
May 30, 2023 — The first treatment, for a patient with prostate cancer, was successfully carried out on April 28. Yonsei ... May 30, 2023 News | Oncology Information Management Systems (OIMS) RayCare is Now Interoperable with Varian TrueBeam May 24, 2023 — RaySearch Laboratories AB ann...
However, there was no significant activity that varied with the expected value of information valence, either within the ROIs, or at a whole-brain FWE-corrected level. This is most likely driven by the fact that decisions on every trial involved assessing two alternatives that differed in the ...